Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics

NEXT STORY
FIRST STUDY OF HOMELESS ENCAMPMENTS FINDS LACK OF AFFORDABLE HOUSING TO BE KEY DRIVER
PREV STORY
Predictmedix and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients

author_avatar
NASDAQ Market News

Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress

author_avatar
NASDAQ Market News

Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News